The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome

Not yet recruiting

• Conditions: Polycystic Ovary Syndrome

• Registration Number: NCT05929950
• Lead Sponsor: Sohag University

Brief Summary

The goal of the study is to detect autoantibodies in the serum of the women with PCOS and evaluate the obesity markers to investigate the the role of autoimmunity and obesity in PCOS

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2023-06-19
• Status Verified: 2023-07
• Study First Submitted QC: 2023-07-01
• Last Update Submitted: 2023-07-01
• Study First Posted: 2023-07-03
• Last Update Posted: 2023-07-03
• Study Start: 2023-08-01
• Primary Completion: 2024-03-01
• Study Completion: 2024-06-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

• patients diagnosed with PCOS according to the Rotterdam (2003) criteria.

Read More

Exclusion Criteria

• Patients with other causes of hyperandrogenism as congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, virilizing ovarian or adrenal tumors and those taking drugs affecting insulin resistance, such as estrogens, oral contraceptives and corticosteroids during the previous three months before the study.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
measuring serum anti-ovarian, anti-nuclear, anti-double stranded and anti-thyroid antibodies	3 months after recruitment	Theses markers will be measured using ELISA technique

Trial Locations

Locations (1)

Sohag university; 🇪🇬 Sohag, Egypt